| Kerry A Harthcock, MD | |
|
1806 W Lincoln Ave, Yakima, WA 98902-2473 | |
| (509) 452-4520 | |
| (509) 452-5224 |
| Full Name | Kerry A Harthcock |
|---|---|
| Gender | Male |
| Speciality | Pediatrics |
| Location | 1806 W Lincoln Ave, Yakima, Washington |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1407951395 | NPI | - | NPPES |
| 009865 | Other | WA | LABOR AND INDUSTRIES |
| 1045640 | Medicaid | WA | |
| 8941847 | Other | WA | L&I CRIME VICTIM NUMBER |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208000000X | Pediatrics | MD00025367 (Washington) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Kerry A Harthcock, MD 1806 W Lincoln Ave, Yakima, WA 98902-2473 Ph: (509) 452-4520 | Kerry A Harthcock, MD 1806 W Lincoln Ave, Yakima, WA 98902-2473 Ph: (509) 452-4520 |
News Archive
New Jersey's sixth cardiac surgery report card shows that mortality rates continued to decline in 2001 to the lowest levels since reporting began in the state, Health and Senior Services Commissioner Clifton R. Lacy, M.D., announced yesterday.
Doctors in Brazil have concluded that the drug amifostine eases many of the most common side effects associated with patients receiving radiation therapy to treat their cancer while simultaneously making the cancer more susceptible to radiation.
Even mild concussions cause severe and long-lasting impairments in the brain's ability to clean itself of toxins, and this may seed it for Alzheimer's disease, dementia and other neurodegenerative problems, new research from the University of Virginia School of Medicine reveals.
Cyclenium Pharma Inc., an emerging pharmaceutical company specializing in the research and development of novel drug candidates based on its proprietary macrocyclic chemistry technology, and Haplogen GmbH, a biotechnology company developing anti-infective drugs, today announced the signing of a research agreement aimed at the discovery of novel pharmaceutical candidates in multiple disease areas.
A detailed study of the monoclonal antibodies from a person who survived a Marburg infection led researchers to identify novel mechanisms that contribute protection against the disease, according to the latest findings of a collaborative team led by The University of Texas Medical Branch at Galveston and Vanderbilt University Medical Center.
› Verified 5 days ago
Stephen J Pearson, M.D. Pediatrics Medicare: Accepting Medicare Assignments Practice Location: 1806 W Lincoln Ave, Yakima, WA 98902 Phone: 509-452-4520 Fax: 509-452-5224 | |
Dr. Elizabeth Lee Engelhardt, MD Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 2811 Tieton Dr, Yakima, WA 98902 Phone: 509-575-8026 Fax: 509-577-5061 | |
Diane Liebe, MD Pediatrics Medicare: Medicare Enrolled Practice Location: 3801 Kern Way, Yakima, WA 98902 Phone: 509-574-3220 Fax: 509-574-3211 | |
Anna L Snyder, MD Pediatrics Medicare: Medicare Enrolled Practice Location: 402 S 12th Ave, Yakima, WA 98902 Phone: 509-575-0114 Fax: 509-575-0808 | |
Ms. Alexis Beinlich, DO Pediatrics Medicare: Accepting Medicare Assignments Practice Location: 2811 Tieton Dr, Yakima, WA 98902 Phone: 509-575-8000 | |
Dr. David W Carlson, D.O. Pediatrics Medicare: Medicare Enrolled Practice Location: 314 S 11th Ave, Suite A, Yakima, WA 98902 Phone: 509-575-0114 Fax: 509-575-0808 | |
Dr. Stephanie Kalila Raghubeer, M.D. Pediatrics Medicare: Medicare Enrolled Practice Location: 2811 Tieton Dr, Yakima, WA 98902 Phone: 509-575-8452 |